Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Expression of the JAK-STAT Signaling Pathway in Pyoderma Gangrenosum Pathological Biopsy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04792957
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:44.695529+00:00
Published At
2022-03-23T00:00:00+00:00
Record Updated At
2022-03-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pyoderma Gangrenosum", "Hidradenitis Suppurativa", "Psoriasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-03-23"
protocolSection.identificationModule.nctId
"NCT04792957"
protocolSection.identificationModule.officialTitle
"Expression of the JAK-STAT Signaling Pathway in Pyoderma Gangrenosum Pathological Biopsy"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Pyoderma Gangrenosum (protocolSection.conditionsModule.conditions)
  • Hidradenitis Suppurativa (protocolSection.conditionsModule.conditions)
  • Psoriasis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.